Robotic surgical systems to grow 15.7% CAGR by 2033

The growth of AI adoption in general surgery is also expected to reach $7.2b.

Integration of artificial intelligence (AI) in the robotic surgical systems market is estimated to grow at a 15.7% compound annual growth rate (CAGR), achieving nearly $7.2b in 2033.

In a report by GlobalData, the growing market in AI utilisation has been driven by global population ageing and increased prevalence of curable ailments like cancer, arthritis, and cardiovascular diseases.

The integration of AI in surgery has promised revolutionary advancements in precision and patient outcomes. Several AI tools have advanced preoperative planning, intraoperative assistance, and postoperative care, improving diagnostic accuracy and treatment strategies.

ALSO READ: Qatar healthcare spending to grow 5.2% in 5 years: report

With substantial growth in AI utilisation and robotic surgical systems, surgery has reached unparalleled precision and effectiveness. Whilst AI adoption, particularly in foreign markets, is still in early stages, the procedure is being used for hysterectomy, colorectal, cancer, and thoracic surgeries.

AI in general surgery also applies to postoperative care and patient management. With predictive analytics and remote monitoring, healthcare providers can proactively monitor postoperative complications, improve rehabilitation protocols, and uphold seamless care continuity.

“As AI integrates seamlessly into surgery, it redefines precision, reshaping outcomes by leveraging advanced algorithms and computational power to navigate complexities with unmatched accuracy, heralding a new era of medical advancement,” Graysen Vigneux, medical analyst at GlobalData, said.